Profile

Chief Executive Officer, Envision Pharma Group

David is Chief Executive Officer at Envision Pharma Group.

He was previously Partner and Managing Director at Alligent BioPharm Consulting, now acquired by Envision Pharma Group (EPG).

Since joining Envision he rapidly progressed from Chief Strategy Officer (2016-2018) to Chief Commercial Officer (2018-2019) before becoming Chief Executive in December 2019.

He is a veteran of the medical communication industry, having spent 17 years with Gardiner-Caldwell, now KnowledgePoint360 Group, in various leadership positions in Europe and in the US and currently sits on EPG’s board.

In 2002, David moved to the US from the UK to set up Gardiner-Caldwell’s US division, which was hugely successful. As Group President in KnowledgePoint360, David continued to run this arm of the company, as well as several other agencies across the US market, working closely with medical affairs and marketing clients from offices in New Jersey, Chicago, San Francisco and Newtown, PA.

David spent his early career with PricewaterhouseCoopers, then worked in education before entering the medical communications field.

David earned a Bachelor of Arts degree in Economics and German from the University of Newcastle-upon-Tyne, and did postgraduate work in Education at the University of Manchester.